BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 15038727)

  • 1. Chemical genetic control of protein levels: selective in vivo targeted degradation.
    Schneekloth JS; Fonseca FN; Koldobskiy M; Mandal A; Deshaies R; Sakamoto K; Crews CM
    J Am Chem Soc; 2004 Mar; 126(12):3748-54. PubMed ID: 15038727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting protein stability with a small molecule.
    Lampson MA; Kapoor TM
    Cell; 2006 Sep; 126(5):827-9. PubMed ID: 16959558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin/proteasome system.
    Magnani M
    Nat Biotechnol; 2000 Aug; 18(8):807. PubMed ID: 10932130
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamics of proteasome distribution in living cells.
    Reits EA; Benham AM; Plougastel B; Neefjes J; Trowsdale J
    EMBO J; 1997 Oct; 16(20):6087-94. PubMed ID: 9321388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
    Dantuma NP; Lindsten K; Glas R; Jellne M; Masucci MG
    Nat Biotechnol; 2000 May; 18(5):538-43. PubMed ID: 10802622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric molecules to target proteins for ubiquitination and degradation.
    Sakamoto KM
    Methods Enzymol; 2005; 399():833-47. PubMed ID: 16338398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera.
    Cogan PS; Koch TH
    J Med Chem; 2004 Nov; 47(23):5690-9. PubMed ID: 15509168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.
    Dantuma NP; Heessen S; Lindsten K; Jellne M; Masucci MG
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8381-5. PubMed ID: 10890896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted protein degradation.
    Zhou P
    Curr Opin Chem Biol; 2005 Feb; 9(1):51-5. PubMed ID: 15701453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome.
    Berse M; Bounpheng M; Huang X; Christy B; Pollmann C; Dubiel W
    J Mol Biol; 2004 Oct; 343(2):361-70. PubMed ID: 15451666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An FKBP12 binding assay based upon biotinylated FKBP12.
    Carreras CW; Fu H; Santi DV
    Anal Biochem; 2001 Nov; 298(1):57-61. PubMed ID: 11673895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin expression is lost in a neural stem cell line through a mechanism involving the proteasome and Notch signalling.
    Mellodew K; Suhr R; Uwanogho DA; Reuter I; Lendahl U; Hodges H; Price J
    Brain Res Dev Brain Res; 2004 Jul; 151(1-2):13-23. PubMed ID: 15246688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of impaired proteasomal function in a cellular model of polyglutamine diseases.
    Jana NR; Nukina N
    Methods Mol Biol; 2004; 277():287-92. PubMed ID: 15201463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.
    Mandrusiak LM; Beitel LK; Wang X; Scanlon TC; Chevalier-Larsen E; Merry DE; Trifiro MA
    Hum Mol Genet; 2003 Jul; 12(13):1497-506. PubMed ID: 12812978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells.
    Farla P; Hersmus R; Geverts B; Mari PO; Nigg AL; Dubbink HJ; Trapman J; Houtsmuller AB
    J Struct Biol; 2004 Jul; 147(1):50-61. PubMed ID: 15109605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent labeling of proteins in living cells using the FKBP12 (F36V) tag.
    Robers M; Pinson P; Leong L; Batchelor RH; Gee KR; Machleidt T
    Cytometry A; 2009 Mar; 75(3):207-24. PubMed ID: 18837033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAT10, a ubiquitin-independent signal for proteasomal degradation.
    Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
    Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.
    Coulombe P; Rodier G; Bonneil E; Thibault P; Meloche S
    Mol Cell Biol; 2004 Jul; 24(14):6140-50. PubMed ID: 15226418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis.
    Kim I; Kim CH; Kim JH; Lee J; Choi JJ; Chen ZA; Lee MG; Chung KC; Hsu CY; Ahn YS
    Exp Cell Res; 2004 Aug; 298(1):229-38. PubMed ID: 15242777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.